A citation-based method for searching scientific literature


List of co-cited articles
41 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


SNP-mediated disruption of CTCF binding at the IFITM3 promoter is associated with risk of severe influenza in humans.
E Kaitlynn Allen, Adrienne G Randolph, Tushar Bhangale, Pranay Dogra, Maikke Ohlson, Christine M Oshansky, Anthony E Zamora, John P Shannon, David Finkelstein, Amy Dressen,[...]. Nat Med 2017
112
88

IFITM3 restricts the morbidity and mortality associated with influenza.
Aaron R Everitt, Simon Clare, Thomas Pertel, Sinu P John, Rachael S Wash, Sarah E Smith, Christopher R Chin, Eric M Feeley, Jennifer S Sims, David J Adams,[...]. Nature 2012
517
88

Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with severe influenza in Chinese individuals.
Yong-Hong Zhang, Yan Zhao, Ning Li, Yan-Chun Peng, Eleni Giannoulatou, Rong-Hua Jin, Hui-Ping Yan, Hao Wu, Jin-Hua Liu, Ning Liu,[...]. Nat Commun 2013
186
77



Antiviral Protection by IFITM3 In Vivo.
Ashley Zani, Jacob S Yount. Curr Clin Microbiol Rep 2018
46
55

Interferon-Induced Transmembrane Protein 3 Genetic Variant rs12252-C Associated With Disease Severity in Coronavirus Disease 2019.
Yonghong Zhang, Ling Qin, Yan Zhao, Ping Zhang, Bin Xu, Kang Li, Lianchun Liang, Chi Zhang, Yanchao Dai, Yingmei Feng,[...]. J Infect Dis 2020
80
44

Population genetics of IFITM3 in Portugal and Central Africa reveals a potential modifier of influenza severity.
Susana David, Vanessa Correia, Liliana Antunes, Ricardo Faria, José Ferrão, Paula Faustino, Baltazar Nunes, Fernando Maltez, João Lavinha, Helena Rebelo de Andrade. Immunogenetics 2018
16
44

Association between IFITM3 rs12252 polymorphism and influenza susceptibility and severity: A meta-analysis.
Suchitra S Prabhu, Trirupa Tapas Chakraborty, Nirmal Kumar, Indranil Banerjee. Gene 2018
26
44

Association between rs12252 and influenza susceptibility and severity: an updated meta-analysis.
T Chen, M Xiao, J Yang, Y K Chen, T Bai, X J Tang, Y L Shu. Epidemiol Infect 2018
13
44

IFITM3, TLR3, and CD55 Gene SNPs and Cumulative Genetic Risks for Severe Outcomes in Chinese Patients With H7N9/H1N1pdm09 Influenza.
Nelson Lee, Bin Cao, Changwen Ke, Hongzhou Lu, Yunwen Hu, Claudia Ha Ting Tam, Ronald Ching Wan Ma, Dawei Guan, Zhaoqin Zhu, Hui Li,[...]. J Infect Dis 2017
39
44

Ifitm3 limits the severity of acute influenza in mice.
Charles C Bailey, I-Chueh Huang, Christina Kam, Michael Farzan. PLoS Pathog 2012
161
33

The CD225 domain of IFITM3 is required for both IFITM protein association and inhibition of influenza A virus and dengue virus replication.
Sinu P John, Christopher R Chin, Jill M Perreira, Eric M Feeley, Aaron M Aker, George Savidis, Sarah E Smith, Andrew E H Elia, Aaron R Everitt, Mehul Vora,[...]. J Virol 2013
123
33


IFITM3 rs12252 T>C polymorphism is associated with the risk of severe influenza: a meta-analysis.
Y Xuan, L N Wang, W Li, H R Zi, Y Guo, W J Yan, X B Chen, P M Wei. Epidemiol Infect 2015
27
33

IFITM3 and susceptibility to respiratory viral infections in the community.
Tara C Mills, Anna Rautanen, Katherine S Elliott, Tom Parks, Vivek Naranbhai, Margareta M Ieven, Christopher C Butler, Paul Little, Theo Verheij, Chris S Garrard,[...]. J Infect Dis 2014
59
33

Rapid interferon independent expression of IFITM3 following T cell activation protects cells from influenza virus infection.
James G Bedford, Meredith O'Keeffe, Patrick C Reading, Linda M Wakim. PLoS One 2019
20
33

The broad-spectrum antiviral functions of IFIT and IFITM proteins.
Michael S Diamond, Michael Farzan. Nat Rev Immunol 2013
473
33


The Interferon-induced transmembrane protein 3 gene (IFITM3) rs12252 C variant is associated with COVID-19.
Juan Gómez, Guillermo M Albaiceta, Elías Cuesta-Llavona, Marta García-Clemente, Carlos López-Larrea, Laura Amado-Rodríguez, Inés López-Alonso, Santiago Melón, Marta E Alvarez-Argüelles, Helena Gil-Peña,[...]. Cytokine 2021
34
33



Lack of Truncated IFITM3 Transcripts in Cells Homozygous for the rs12252-C Variant That is Associated With Severe Influenza Infection.
Shokouh Makvandi-Nejad, Henry Laurenson-Schafer, LiLi Wang, Dannielle Wellington, Yan Zhao, Boquan Jin, Ling Qin, Kerry Kite, Hooman K Moghadam, Chaojun Song,[...]. J Infect Dis 2018
26
22

IFITM proteins-cellular inhibitors of viral entry.
Se Smith, S Weston, P Kellam, M Marsh. Curr Opin Virol 2014
81
22

IFITM-Family Proteins: The Cell's First Line of Antiviral Defense.
Charles C Bailey, Guocai Zhong, I-Chueh Huang, Michael Farzan. Annu Rev Virol 2014
256
22

IFITM Genes, Variants, and Their Roles in the Control and Pathogenesis of Viral Infections.
Xuesen Zhao, Jiarui Li, Cheryl A Winkler, Ping An, Ju-Tao Guo. Front Microbiol 2019
65
22

IFITMs restrict the replication of multiple pathogenic viruses.
Jill M Perreira, Christopher R Chin, Eric M Feeley, Abraham L Brass. J Mol Biol 2013
153
22

IFITM3 Rs12252-C Variant Increases Potential Risk for Severe Influenza Virus Infection in Chinese Population.
Yang Pan, Peng Yang, Tao Dong, Yi Zhang, Weixian Shi, Xiaomin Peng, Shujuan Cui, Daitao Zhang, Guilan Lu, Yimeng Liu,[...]. Front Cell Infect Microbiol 2017
22
22

The IFITM protein family in adaptive immunity.
Diana C Yánez, Susan Ross, Tessa Crompton. Immunology 2020
43
22

IFITM3 directly engages and shuttles incoming virus particles to lysosomes.
Jennifer S Spence, Ruina He, Hans-Heinrich Hoffmann, Tandrila Das, Emmanuelle Thinon, Charles M Rice, Tao Peng, Kartik Chandran, Howard C Hang. Nat Chem Biol 2019
109
22

Hospitalization Risk Due to Respiratory Illness Associated with Genetic Variation at IFITM3 in Patients with Influenza A(H1N1)pdm09 Infection: A Case-Control Study.
Vânia Gaio, Baltazar Nunes, Pedro Pechirra, Patrícia Conde, Raquel Guiomar, Carlos Matias Dias, Marta Barreto. PLoS One 2016
14
22

IFITM3 inhibits influenza A virus infection by preventing cytosolic entry.
Eric M Feeley, Jennifer S Sims, Sinu P John, Christopher R Chin, Thomas Pertel, Li-Mei Chen, Gaurav D Gaiha, Bethany J Ryan, Ruben O Donis, Stephen J Elledge,[...]. PLoS Pathog 2011
265
22


Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus.
I-Chueh Huang, Charles C Bailey, Jessica L Weyer, Sheli R Radoshitzky, Michelle M Becker, Jessica J Chiang, Abraham L Brass, Asim A Ahmed, Xiaoli Chi, Lian Dong,[...]. PLoS Pathog 2011
415
22

Transcriptome differences in the rumen of beef steers with variation in feed intake and gain.
Rebecca J Kern, Amanda K Lindholm-Perry, Harvey C Freetly, Warren M Snelling, John W Kern, John W Keele, Jeremy R Miles, Andrew P Foote, William T Oliver, Larry A Kuehn,[...]. Gene 2016
24
22

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. BMJ 2009
22

Interferon-Inducible Transmembrane Protein 3 Genetic Variant rs12252 and Influenza Susceptibility and Severity: A Meta-Analysis.
Xianxian Yang, Bin Tan, Xipeng Zhou, Jian Xue, Xian Zhang, Peng Wang, Chuang Shao, Yingli Li, Chaorui Li, Huiming Xia,[...]. PLoS One 2015
32
22

The innate immunity protein IFITM3 modulates γ-secretase in Alzheimer's disease.
Ji-Yeun Hur, Georgia R Frost, Xianzhong Wu, Christina Crump, Si Jia Pan, Eitan Wong, Marilia Barros, Thomas Li, Pengju Nie, Yujia Zhai,[...]. Nature 2020
84
22

Association between the interferon-induced transmembrane protein 3 gene (IFITM3) rs34481144 / rs12252 haplotypes and COVID-19.
Elías Cuesta-Llavona, Guillermo M Albaiceta, Marta García-Clemente, Israel D Duarte-Herrera, Laura Amado-Rodríguez, Tamara Hermida-Valverde, Ana I Enríquez-Rodriguez, Cristina Hernández-González, Santiago Melón, Marta E Alvarez-Argüelles,[...]. Curr Res Virol Sci 2021
8
25

The influence of IFITM3 polymorphisms on susceptibility to SARS-CoV-2 infection and severity of COVID-19.
Kristina Schönfelder, Katharina Breuckmann, Carina Elsner, Ulf Dittmer, David Fistera, Frank Herbstreit, Joachim Risse, Karsten Schmidt, Sivagurunathan Sutharsan, Christian Taube,[...]. Cytokine 2021
16
22

Interferon-induced transmembrane protein-3 genetic variant rs12252 is associated with COVID-19 mortality.
Jahad Alghamdi, Manal Alaamery, Tlili Barhoumi, Mamoon Rashid, Hala Alajmi, Nasser Aljasser, Yaseen Alhendi, Hind Alkhalaf, Hanadi Alqahtani, Omer Algablan,[...]. Genomics 2021
12
22

Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses.
Zeinab Abdelrahman, Mengyuan Li, Xiaosheng Wang. Front Immunol 2020
113
11

The novel zoonotic COVID-19 pandemic: An expected global health concern.
Carlo Contini, Mariachiara Di Nuzzo, Nicole Barp, Aurora Bonazza, Roberto De Giorgio, Mauro Tognon, Salvatore Rubino. J Infect Dev Ctries 2020
90
11


Lack of Association Between Genetic Variants at ACE2 and TMPRSS2 Genes Involved in SARS-CoV-2 Infection and Human Quantitative Phenotypes.
Esteban A Lopera Maya, Adriaan van der Graaf, Pauline Lanting, Marije van der Geest, Jingyuan Fu, Morris Swertz, Lude Franke, Cisca Wijmenga, Patrick Deelen, Alexandra Zhernakova,[...]. Front Genet 2020
29
11

Innate Immunity and Influenza A Virus Pathogenesis: Lessons for COVID-19.
Kevan L Hartshorn. Front Cell Infect Microbiol 2020
9
11

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
Markus Hoffmann, Hannah Kleine-Weber, Simon Schroeder, Nadine Krüger, Tanja Herrler, Sandra Erichsen, Tobias S Schiergens, Georg Herrler, Nai-Huei Wu, Andreas Nitsche,[...]. Cell 2020
11

Genomewide Association Study of Severe Covid-19 with Respiratory Failure.
David Ellinghaus, Frauke Degenhardt, Luis Bujanda, Maria Buti, Agustín Albillos, Pietro Invernizzi, Javier Fernández, Daniele Prati, Guido Baselli, Rosanna Asselta,[...]. N Engl J Med 2020
919
11

IFITM proteins restrict viral membrane hemifusion.
Kun Li, Ruben M Markosyan, Yi-Min Zheng, Ottavia Golfetto, Brittani Bungart, Minghua Li, Shilei Ding, Yuxian He, Chen Liang, James C Lee,[...]. PLoS Pathog 2013
234
11



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.